SIGHT SCIENCES SGHT 深 沪
已收盘 08-29 16:00:00 美东时间
4.06
+0.020
+0.50%
华盛通- 最 高4.08
- 今 开4.07
- 成交量 5.99万股
- 最 低 3.95
- 昨 收 4.04
- 总市值 2.13亿
- 52周最高 7.03
- 市盈率 静 --
- 换手率 0.11%
- 52周最低 2.03
- 委 比 -10.48%
- 总股本 5236.74万
- 历史最高 42.57
- 量 比 0.43
- 振 幅 3.22%
- 历史最低 1.04
- 每 手 1
- 风险率 1.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Needham Reiterates Hold on Sight Sciencesto Hold
Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) from Hold to Hold.
08-29 00:44
Sight Sciences Announces Workforce Reduction Plan
The latest announcement is out from Sight Sciences ( ($SGHT) ). On August 27, 2...
08-28 04:35
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
Sight Sciences, an eyecare technology company, announced that it will present at the Morgan Stanley Global Healthcare Conference on September 10, 2025. The presentation will be accessible via webcast on the company's website. Sight Sciences focuses on developing innovative solutions for eye diseases, particularly glaucoma and dry eye, through minimally invasive technologies. Its products, including the OMNI Surgical System and TearCare® System, a...
08-26 20:05
美股大行评级 | Analog Devices获大摩、小摩、富国银行等四家机构"超配"评级，目标价最高升至310美元
今日重点评级关注：摩根大通：维持Analog Devices"超配"评级，目标价从300美元升至310美元；花旗：维持梅特勒-托利多"买入"评级，目标价从1400美元升至1600美元
08-22 09:57
What 4 Analyst Ratings Have To Say About Sight Sciences
Sight Sciences (NASDAQ:SGHT) has been analyzed by 4 analysts in the last three ...
08-22 03:00
Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $4.5
Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3.6 to $4.5.
08-22 02:14
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
Lake Street Upgrades Sight Sciences to Buy, Raises Price Target to $5
Lake Street analyst Frank Takkinen upgrades Sight Sciences (NASDAQ:SGHT) from Hold to Buy and raises the price target from $3 to $5.
08-09 06:18
Sight Sciences Raises Full-Year Revenue Guidance
An update from Sight Sciences ( ($SGHT) ) is now available. On August 7, 2025, ...
08-08 04:42
Sight Sciences Q2 EPS $(0.23) Beats $(0.29) Estimate, Sales $19.564M Beat $18.183M Estimate
Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29) by 20.69 percent. This is a 8 percent increase over losses of $(0.25) per share from the
08-08 04:09
